LENSAR, Inc. (LNSR) Earnings Call Transcripts
LENSAR, Inc.'s Latest Earnings Call - Q1 FY2026
In the first quarter of 2026, LENSAR, Inc. reported total revenue of $13.4 million, a decline of 5% year-over-year, primarily due to lower system capital sales. However, recurring revenue grew by 9% to $12.6 million, representing 94% of total revenue, indicating strong underlying demand for its ALLY system. Management emphasized a shift towards rebuilding growth momentum and expanding the installed base, with a focus on increasing recurring revenue as they transition out of a merger-related holding pattern. The company did not provide specific guidance but expressed optimism for future growth as they reestablish their market position.
Reported metrics
| Metric | Value |
|---|---|
| Total Revenue | $13.4 million (miss) |
| Recurring Revenue | $12.6 million (beat) |
| Net Income | $36.3 million (beat) |
| Gross Margin | 48% (miss) |
| Operating Expenses | $4.1 million (beat) |
| ALLY Installed Base | 205 systems (positive) |
Guidance from management
Management did not provide specific guidance but expressed optimism about returning to growth, particularly in recurring revenue and system placements as they rebuild their business post-merger termination.
What management said
That's post quarter end. It's going to take us -- just to very succinctly, it's going to take us the next couple of quarters. I really expect the next few quarters to be this like steady progress of rebuilding and improvement here. I think the really great story is that our recurring revenue is so strong and that it continues to grow. And I feel that's going to continue. So now as we start adding additional placement...
So I was just going to address your procedure question, which is when you look at the procedure growth in the quarter, it is solely related to U.S. activity. So Nick and I can't -- I guess we can't emphasize enough that when the acquisition was announced, there was a slow turn-off of our distributor activity. And so you see that in not only procedure volume, but more importantly, in placements. And so right now, the ...
What analysts pressed on
Analysts expressed concerns about the pace of recovery in system placements and the impact of the terminated merger on future growth. There were questions regarding the timing of distributor re-engagement and the potential for operational expenses to increase as the company rebuilds its workforce.
Main topics on the call
- Recurring Revenue Growth — LENSAR's recurring revenue increased by 9% year-over-year, reaching $12.6 million, which represents 94% of total revenue. Management stated, 'We're reaching an inflection point where the size of our installed base is inc...
- Impact of Terminated Merger — The termination of the merger with Alcon has allowed LENSAR to refocus on its core business. CEO Nick Curtis noted, 'We spent most of quarter 1 in the state of limbo,' but now they are optimistic about rebuilding their g...
- System Placements — LENSAR placed 7 ALLY systems during the quarter, bringing the total installed base to 205 systems. Despite the decline in placements, management highlighted that 'the continued strength in the recurring revenue' is a mor...
- Procedure Volume Growth — The company performed approximately 54,000 procedures in Q1 2026, up from about 52,000 in Q1 2025. Management indicated that they expect to regain market share as they convert competitive system users.
Read the full LENSAR, Inc. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About LENSAR, Inc.
LENSAR, Inc. (LNSR) is a publicly listed company in the Health Care Equipment and Supplies industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 16 calls on record spanning November 8, 2021 to May 8, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 16 LENSAR, Inc. earnings call transcripts on record, spanning November 8, 2021 to May 8, 2026. Based on this history, LENSAR, Inc. reports quarterly. The most recent call on file is dated May 8, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- LNSR
- Exchange
- NasdaqCM
- Country
- US
- Sector
- Health Care
- Calls on record
- 16
- First call
- November 8, 2021
- Most recent
- May 8, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Q1 FY2026 | May 8, 2026 | Read transcript → |
| Q4 FY2025 | Mar 31, 2026 | Read transcript → |
| Q4 FY2024 | Feb 27, 2025 | Read transcript → |
| Q3 FY2024 | Nov 7, 2024 | Read transcript → |
| Q2 FY2024 | Aug 8, 2024 | Read transcript → |
| Q1 FY2024 | May 9, 2024 | Read transcript → |
| Q4 FY2023 | Mar 4, 2024 | Read transcript → |
| Q3 FY2023 | Nov 9, 2023 | Read transcript → |
| Q2 FY2023 | Aug 9, 2023 | Read transcript → |
| Q1 FY2023 | May 15, 2023 | Read transcript → |
| Q4 FY2022 | Mar 16, 2023 | Read transcript → |
| Q3 FY2022 | Nov 9, 2022 | Read transcript → |
| Q2 FY2022 | Aug 8, 2022 | Read transcript → |
| Q1 FY2022 | May 9, 2022 | Read transcript → |
| Q4 FY2021 | Mar 3, 2022 | Read transcript → |
| Q3 FY2021 | Nov 8, 2021 | Read transcript → |